CLINICAL_TRIALS
trial_result
· 2016-10-31
Clinical Trial Update: Everolimus in Treating Cutaneous T-cell Lymphoma [Phase 2]
Summary
A Phase 2 trial of everolimus for cutaneous T-cell lymphoma was terminated, with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Adam Lerner | Conditions: Cutaneous T-Cell Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2016-10-31